Latest Eversept Partners, LP Stock Portfolio
$1.46Billion– No. of Holdings #72
Eversept Partners, LP Performance:
2024 Q2: 1.87%YTD: 19.63%2023: 3.59%
Performance for 2024 Q2 is 1.87%, and YTD is 19.63%, and 2023 is 3.59%.
About Eversept Partners, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Eversept Partners, LP reported an equity portfolio of $1.5 Billions as of 30 Jun, 2024.
The top stock holdings of Eversept Partners, LP are , NTRA, INSM. The fund has invested 9.1% of it's portfolio in GSK PLC and 8.7% of portfolio in NATERA INC.
The fund managers got completely rid off PFIZER INC (PFE), SHOCKWAVE MED INC (SWAV) and TENET HEALTHCARE CORP (THC) stocks. They significantly reduced their stock positions in STOKE THERAPEUTICS INC (STOK), GUARDANT HEALTH INC (GH) and SERES THERAPEUTICS INC (MCRB). Eversept Partners, LP opened new stock positions in INSMED INC (INSM), SPDR SER TR (BIL) and ARCUTIS BIOTHERAPEUTICS INC (ARQT). The fund showed a lot of confidence in some stocks as they added substantially to REPLIGEN CORP (RGEN), VIKING THERAPEUTICS INC (VKTX) and VIRIDIAN THERAPEUTICS INC (VRDN).
The top stock holdings of Eversept Partners, LP are , NTRA, INSM. The fund has invested 9.1% of it's portfolio in GSK PLC and 8.7% of portfolio in NATERA INC.
The fund managers got completely rid off PFIZER INC (PFE), SHOCKWAVE MED INC (SWAV) and TENET HEALTHCARE CORP (THC) stocks. They significantly reduced their stock positions in STOKE THERAPEUTICS INC (STOK), GUARDANT HEALTH INC (GH) and SERES THERAPEUTICS INC (MCRB). Eversept Partners, LP opened new stock positions in INSMED INC (INSM), SPDR SER TR (BIL) and ARCUTIS BIOTHERAPEUTICS INC (ARQT). The fund showed a lot of confidence in some stocks as they added substantially to REPLIGEN CORP (RGEN), VIKING THERAPEUTICS INC (VKTX) and VIRIDIAN THERAPEUTICS INC (VRDN).
Eversept Partners, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Eversept Partners, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Eversept Partners, LP made a return of 1.87% in the last quarter. In trailing 12 months, it's portfolio return was 26.21%.
New Buys
| Ticker | $ Bought |
|---|---|
| insmed inc | 77,424,400 |
| spdr ser tr | 9,271,000 |
| arcutis biotherapeutics inc | 7,791,980 |
| cytokinetics inc | 6,874,200 |
| evolus inc | 6,232,910 |
| oscar health inc | 4,918,330 |
| cerevel therapeutics hldng i | 4,498,310 |
| myriad genetics inc | 4,450,770 |
New stocks bought by Eversept Partners, LP
Additions
| Ticker | % Inc. |
|---|---|
| repligen corp | 2,258 |
| viking therapeutics inc | 506 |
| viridian therapeutics inc | 299 |
| molina healthcare inc | 213 |
| novo-nordisk a s | 135 |
| eli lilly & co | 64.89 |
| sutro biopharma inc | 59.35 |
| zimvie inc | 35.99 |
Additions to existing portfolio by Eversept Partners, LP
Reductions
| Ticker | % Reduced |
|---|---|
| stoke therapeutics inc | -78.87 |
| guardant health inc | -77.9 |
| seres therapeutics inc | -69.89 |
| immunovant inc | -63.64 |
| vaxcyte inc | -51.31 |
| merus n v | -44.36 |
| argenx se | -36.55 |
| natera inc | -34.00 |
Eversept Partners, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| taysha gene therapies inc | -6,674,450 |
| pfizer inc | -30,581,700 |
| curevac n v | -1,562,540 |
| taro pharmaceutical inds ltd | -11,158,300 |
| tenet healthcare corp | -18,460,600 |
| morphosys ag | -3,009,860 |
| corbus pharmaceuticals hldgs | -3,489,770 |
| shockwave med inc | -26,231,100 |
Eversept Partners, LP got rid off the above stocks
Sector Distribution
Eversept Partners, LP has about 81.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 81.7 |
| Others | 18.1 |
Market Cap. Distribution
Eversept Partners, LP has about 40% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 38.5 |
| MID-CAP | 24.2 |
| UNALLOCATED | 18.9 |
| SMALL-CAP | 14.7 |
| MICRO-CAP | 2.2 |
| MEGA-CAP | 1.5 |
Stocks belong to which Index?
About 48.9% of the stocks held by Eversept Partners, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 51.1 |
| RUSSELL 2000 | 36.4 |
| S&P 500 | 12.5 |
Eversept Partners, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Eversept Partners, LP
Eversept Partners, LP has 72 stocks in it's portfolio. About 54.8% of the portfolio is in top 10 stocks. INSP proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Eversept Partners, LP last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.07 | 325,509 | 1,002,570 | new | |||
| ALEC | alector inc | 0.17 | 541,739 | 2,459,500 | added | 1.04 | ||
| AMRN | amarin corp plc | 0.20 | 4,308,530 | 2,964,270 | reduced | -30.65 | ||
| ARQT | arcutis biotherapeutics inc | 0.53 | 837,847 | 7,791,980 | new | |||
| AUTL | autolus therapeutics plc | 0.15 | 610,902 | 2,125,940 | new | |||
| AVTE | aerovate therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTR | avantor inc | 0.18 | 125,394 | 2,658,350 | unchanged | 0.00 | ||
| BCRX | biocryst pharmaceuticals inc | 0.49 | 1,152,570 | 7,122,900 | reduced | -19.54 | ||
| BIL | spdr ser tr | 0.64 | 100,000 | 9,271,000 | new | |||
| BKD | brookdale sr living inc | 0.72 | 1,546,840 | 10,564,900 | added | 17.29 | ||
| CERE | cerevel therapeutics hldng i | 0.31 | 110,010 | 4,498,310 | new | |||
| CLDX | celldex therapeutics inc new | 1.60 | 633,015 | 23,427,900 | reduced | -10.98 | ||
| CNC | centene corp del | 0.53 | 115,820 | 7,678,870 | added | 24.82 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVAC | curevac n v | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYH | community health sys inc new | 1.85 | 8,037,470 | 27,005,900 | added | 0.71 | ||
| CYTK | cytokinetics inc | 0.47 | 126,877 | 6,874,200 | new | |||
| DHR | danaher corporation | 0.70 | 40,855 | 10,207,600 | unchanged | 0.00 | ||
| ELV | elevance health inc | 0.54 | 14,657 | 7,942,040 | added | 1.83 | ||
| EOLS | evolus inc | 0.43 | 574,462 | 6,232,910 | new | |||